| Name | (4S,6R,7S,10R,E)-3-(acetoxymethyl)-7-hydroxy-6,10-dimethyl-2-oxo-2,4,5,6,7,8,9,10-octahydro-7,10-epoxycyclodeca[b]furan-4-yl methacrylate |
|---|---|
| Synonyms |
[(1R,2E,8S,10R,11S)-6-(Acetyloxymethyl)-11-hydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.03,7]tetradeca-2,6-dien-8-yl] 2-meth ylprop-2-enoate
8alpha-(2-Methylacryloyloxy)hirsutinolide 13-O-acetate 8α-(2-Methylacryloyloxy) hirsutinolide 13-O-acetate 2-Propenoic acid, 2-methyl-, (4S,6R,7S,10R,11E)-3-[(acetyloxy)methyl]-2,4,5,6,7,8,9,10-octahydro-7-hydroxy-6,10-dimethyl-2-oxo-7,10-oxycyclodeca[b]furan-4-yl ester |
| Description | 8α-(2-Methylacryloyloxy)-hirsutinolide-13-O-acetate is an irreversible CYP2A6 inhibitor with IC50s of 8.64 μM and 22.3 μM with pre-incubation and co-incubaition, respectively. 8α-(2-Methylacryloyloxy)-hirsutinolide-13-O-acetate also inhibits MAO-A and MAO-B with IC50s of 60.2 and 38.6 μM, respectively[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 8.64 μM (CYP2A6, pre-incubation), 22.3 μM (CYP2A6, co-incubation), 38.6 μM (MAO-B), 60.2 μM(MAO-A)[1] Ki: 15.1 μM (CYP2A6), 27.2 μM (MAO-B), 60.2 μM (MAO-A)[1] |
| References |
| Molecular Formula | C21H26O8 |
|---|---|
| Molecular Weight | 406.42600 |
| Exact Mass | 406.16300 |
| PSA | 108.36000 |
| LogP | 2.07220 |
| Hazard Codes | Xi |
|---|